CA1089448A - Process for purifying glucagon - Google Patents

Process for purifying glucagon

Info

Publication number
CA1089448A
CA1089448A CA275,504A CA275504A CA1089448A CA 1089448 A CA1089448 A CA 1089448A CA 275504 A CA275504 A CA 275504A CA 1089448 A CA1089448 A CA 1089448A
Authority
CA
Canada
Prior art keywords
glucagon
percent
column
gel
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA275,504A
Other languages
English (en)
French (fr)
Inventor
John G. Stilz
Richard L. Jackson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of CA1089448A publication Critical patent/CA1089448A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
CA275,504A 1975-12-17 1977-04-04 Process for purifying glucagon Expired CA1089448A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/641,419 US4033941A (en) 1975-12-17 1975-12-17 Process for purifying glucagon

Publications (1)

Publication Number Publication Date
CA1089448A true CA1089448A (en) 1980-11-11

Family

ID=24572291

Family Applications (1)

Application Number Title Priority Date Filing Date
CA275,504A Expired CA1089448A (en) 1975-12-17 1977-04-04 Process for purifying glucagon

Country Status (7)

Country Link
US (1) US4033941A (en:Method)
CA (1) CA1089448A (en:Method)
DE (1) DE2721027A1 (en:Method)
FR (1) FR2389598B1 (en:Method)
GB (1) GB1576344A (en:Method)
NL (1) NL7703758A (en:Method)
SE (1) SE443512B (en:Method)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4617376A (en) * 1985-07-01 1986-10-14 Eli Lilly And Company Process for recovering glucagon from pancreas glands
CA1284000C (en) * 1985-07-01 1991-05-07 David Gregory Maskalick Process for recovering glucagon from pancreas glands
EP2049149B1 (en) 2006-07-31 2015-04-15 Novo Nordisk A/S Pegylated extended insulins
ES2601839T3 (es) * 2006-09-22 2017-02-16 Novo Nordisk A/S Análogos de insulina resistentes a proteasas
WO2008132224A2 (en) * 2007-04-30 2008-11-06 Novo Nordisk A/S Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein
MX2009012789A (es) * 2007-06-01 2009-12-10 Novo Nordisk As Composiciones farmaceuticas no acuosas estables.
JP5762001B2 (ja) * 2008-03-14 2015-08-12 ノボ・ノルデイスク・エー／エス プロテアーゼ安定化インスリンアナログ
EP2910571B1 (en) 2008-03-18 2016-10-05 Novo Nordisk A/S Protease stabilized, acylated insulin analogues
CN104364260B (zh) 2012-04-11 2017-02-22 诺和诺德股份有限公司 胰岛素制剂
MX366636B (es) 2013-10-07 2019-07-17 Novo Nordisk As Nuevo derivado de un análogo de insulina.
CA3046583A1 (en) 2016-12-16 2018-06-21 Novo Nordisk A/S Insulin containing pharmaceutical compositions
DK3517543T3 (da) 2018-01-30 2020-12-07 Bachem Ag Fremstilling af glucagonpeptider
CN113024658B (zh) * 2019-12-25 2022-10-21 翰宇药业（武汉）有限公司 一种纯化利拉鲁肽的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3715345A (en) * 1970-08-03 1973-02-06 Lilly Co Eli Glucagon separation process
DE2258080C3 (de) * 1972-11-27 1981-12-17 Eli Lilly And Co., Indianapolis, Ind. Verfahren zur Gewinnung von Hexatriacontapeptiden
US3878186A (en) * 1973-05-09 1975-04-15 Lilly Co Eli Process for purifying insulin
US3875138A (en) * 1973-09-27 1975-04-01 Lilly Co Eli Process for recovering glucagon

Also Published As

Publication number Publication date
FR2389598A1 (en:Method) 1978-12-01
NL7703758A (nl) 1978-10-09
GB1576344A (en) 1980-10-08
DE2721027A1 (de) 1978-11-16
FR2389598B1 (en:Method) 1981-06-19
US4033941A (en) 1977-07-05
SE7705162L (sv) 1978-11-04
SE443512B (sv) 1986-03-03

Similar Documents

Publication Publication Date Title
CA1089448A (en) Process for purifying glucagon
Racker [127] Glutathione reductase1 (liver and yeast)
Arakawa et al. The effects of arginine on protein binding and elution in hydrophobic interaction and ion-exchange chromatography
Coelingh et al. Isolation and partial characterization of a basic protein from bovine sperm heads
US5028586A (en) Insulin derivatives and pharmaceutical preparations containing these derivatives
CA1340972C (en) Follistatin and method of purifying same
US5157021A (en) Insulin derivatives and pharmaceutical preparations containing these derivatives
US3876623A (en) Process for purifying insulin
US3907676A (en) Process for purifying insulin
NO146698B (no) Fremgangsmaate for fremstilling av et stabilt langtidsvirkende insulinprodukt
Pflumm et al. Optical Activity of Cystine-containing Proteins: III. Circular dichroism spectra of reduced and reoxidized pancreatic ribonuclease
Frieden et al. Studies of the enzyme fumarase. II. 1 Isolation and physical properties of crystalline enzyme
CA1253997A (en) Process for purifying growth hormone-like materials
EP0013826A1 (en) Process for purifying insulin and insulin so prepared
US4617376A (en) Process for recovering glucagon from pancreas glands
Carlson et al. Crystallization of glycerol 3-phosphate dehydrogenase, triosephosphate dehydrogenase, arginine kinase, and cytochrome c from a single extract of honeybees
CA1284000C (en) Process for recovering glucagon from pancreas glands
Gill et al. Expression and purification of the cytoplasmic N-terminal domain of the Na/HCO3 cotransporter NBCe1-A: structural insights from a generalized approach
US3687833A (en) Purification of lactogen
US3875138A (en) Process for recovering glucagon
Ozawa Reaction of insulin with ethyl glycinate and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide
US2974088A (en) Method of preparing growth hormone
US3637462A (en) Purification of enzymes
WO1990000177A1 (en) Improved process for purifying insulin
US4268631A (en) Apoglucose oxidase preparation

Legal Events

Date Code Title Description
MKEX Expiry